Depression in AMD patients with low vision can be halved by integrated therapies

First clinical trial of integrated approach underlines need for inclusion of behavior activation therapy in low vision rehabilitation

2014-07-09

(Press-News.org) SAN FRANCISCO – July 9, 2014 – The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD). The results of the study were published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

Low vision is a visual impairment that interferes with a person's ability to perform everyday tasks and cannot be corrected with glasses, contact lenses, medicine or surgery. A common cause of low vision is AMD, a condition that causes irreversible vision loss in a majority of cases. An estimated 11 million Americans currently have AMD, and the prevalence is expected to grow to 21.6 million persons by 2050. Up to 30 percent of those living with AMD develop depression, which is associated with higher levels of disability, medical costs and mortality. Despite this, many depressed persons receive no treatment because they perceive depression as a personal failure or an expected part of aging, they are uncertain how to access specialty care, or their physicians lack the resources to effectively diagnose and treat depression.

Currently, the most common treatment for low vision due to AMD is low vision rehabilitation. This treatment involves the assessment of a patient's functional vision, prescription of assistive devices and instruction in the use of these devices, but it does not include any form of psychological support for the patient. To investigate the value of integrating psychological therapy with low vision rehabilitation, a group of researchers from the Sidney Kimmel Medical College at Thomas Jefferson University, Dartmouth Medical School and Johns Hopkins School of Medicine studied 188 patients, averaging 84 years of age, with AMD in both eyes and early signs of depression.

Named the Low VIsion Depression Prevention TriAL (VITAL), the 2013 study first provided all participants each with two sessions of outpatient low vision optometric rehabilitation in clinics. Then the patients were randomly assigned to two types of psychological therapy: either six one-hour sessions of in-home behavior activation over eight weeks or six one-hour sessions of in-home supportive therapy over eight weeks, which served as a control. Behavior activation promotes self-sufficiency and social connections to improve mood and counter withdrawal. Delivering behavior activation in the context of low vision occupational therapy involves environmental modifications, such as marking specific temperatures on the thermostat with high-contrast markers, and aims to improve functional vision as well as help patients achieve valued personal and functional goals. Nondirective supportive therapy facilitates personal expression about illness, disability and vision loss.

After four months, the researchers assessed eight variables, including depression, vision status, vision-related quality of life, physical health status and device use, and found that the incidence of depressive disorders was half in the behavior activation group than of that in the supportive therapy group (12.6 percent versus 23.7 percent, respectively). The rate of depression found in the supportive therapy group was also similar to that reported in the absence of any treatment.

The risk reduction was strongest in participants with worse vision than in participants with better vision (20 percent versus 3.4 percent, respectively). In addition, behavior activation was associated with improved near functional vision, but the difference between the two groups was not statistically different. The researchers also found that participants who self-rated their own health lower were associated with a higher incidence of depression regardless of the treatment used, indicating that those with worse health perceptions require more intensive intervention.

"Our findings demonstrate that referring patients with AMD-related low vision for low vision optometric rehabilitation alone does not fully meet the patients' rehabilitative needs," said Barry W. Rovner, M.D., the trial's lead researcher. "Although low vision occupational therapists do not currently receive training in mental health care, our results indicate that interdisciplinary care like this could significantly help reduce the incidence of depression in patients with AMD."

The American Academy of Ophthalmology encourages ophthalmologists to provide information about rehabilitation resources to patients with vision loss and, when available, referral to multidisciplinary rehabilitation and group support that focuses on social activation, problem-solving and self-management skills.

INFORMATION: For more information about AMD, low vision and general eye health, visit the American Academy of Ophthalmology's public education website at http://www.geteyesmart.org.

The July 2014 issue of Ophthalmology, in print now, features a number of new research reports, including:

Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting
Corneal collagen cross-linking with ultraviolet A light and photoactivated riboflavin may represent a promising adjuvant therapy in the treatment of advanced microbial keratitis associated with corneal melting.

Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma Suspect Eyes
In glaucoma suspect eyes, faster rates of longitudinal retinal nerve fiber layer loss as measured with spectral-domain optical coherence tomography were significantly associated with higher risk of developing visual field damage.

Vision Loss and Hearing Loss in Painting and Musical Composition
The effects of impaired vision and hearing on painting and composing are analyzed. Poor vision limits painting, but also complicates the writing of music. Deafness can be circumvented through reading music, but tinnitus is disruptive.

About the American Academy of Ophthalmology The American Academy of Ophthalmology, headquartered in San Francisco, is the world's largest association of eye physicians and surgeons — Eye M.D.s— with more than 32,000 members worldwide. Eye health care is provided by the three "O's" – ophthalmologists, optometrists, and opticians. It is the ophthalmologist, or Eye M.D., who has the education and training to treat it all: eye diseases, infections and injuries, and perform eye surgery. For more information, visit http://www.aao.org.

The Academy's EyeSmart® program educates the public about the importance of eye health and empowers them to preserve healthy vision. EyeSmart provides the most trusted and medically accurate information about eye diseases, conditions and injuries. OjosSanos™ is the Spanish-language version of the program. Visit http://www.geteyesmart.org or http://www.ojossanos.org to learn more.

About Ophthalmology Ophthalmology, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically-applicable research. Topics include the results of clinical trials, new diagnostic and surgical techniques, treatment methods, technology assessments, translational science reviews and editorials. For more information, visit http://www.aaojournal.org. END

ELSE PRESS RELEASES FROM THIS DATE:

Rehabilitation helps prevent depression from age-related vision loss

2014-07-09

Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half. The study was funded by the National Eye Institute (NEI), part of the National Institutes of Health. "Our results emphasize the high risk of depression from AMD, and the benefits of multi-disciplinary treatment that bridges primary eye care, psychiatry, psychology, and rehabilitation," said Barry Rovner, M.D., a professor of psychiatry and neurology at the Sidney Kimmel Medical ...

Researchers led by Stanford engineer figure out how to make more efficient fuel cells

2014-07-09

Solar power and other sources of renewable energy can help combat global warming but they have a drawback: they don't produce energy as predictably as plants powered by oil, coal or natural gas. Solar panels only produce electricity when the sun is shining, and wind turbines are only productive when the wind is brisk. Ideally, alternative energy sources would be complemented with massive systems to store and dispense power – think batteries on steroids. Reversible fuel cells have been envisioned as one such storage solution. Fuel cells use oxygen and hydrogen as fuel ...

Children on dairy farms less likely to develop allergies

2014-07-09

The occurrence of allergic diseases has risen dramatically in Western societies. One frequently cited reason is that children are less exposed to microorganisms and have fewer infections than previous generations, thereby delaying maturation of the immune system. A study by researchers at Sahlgrenska Academy, University of Gothenburg, monitored children until the age of three to examine maturation of the immune system in relation to allergic disease. All of the children lived in rural areas of the Västra Götaland Region, half of them on farms that produced milk. Lower ...

USC scientists discover immune system component that resists sepsis in mice

2014-07-09

Molecular microbiologists from the Keck School of Medicine of the University of Southern California (USC) have discovered that mice lacking a specific component of the immune system are completely resistant to sepsis, a potentially fatal complication of infection. The discovery suggests that blocking this immune system component may help reduce inflammation in human autoimmune and hyper-inflammatory diseases such as rheumatoid arthritis and Type 2 diabetes. The study was published online on June 23 in The Journal of Experimental Medicine, a leading peer-reviewed scientific ...

Thyroid hormone protects hippocampal cholinergic neurons in normal aged animals

2014-07-09

Can thyroid hormone protect neuronal function and increase the survival rate of naturally aged animals? Prof. Ailing Fu and her team, School of Pharmaceutical Sciences, Southwest University, China performed an animal experiment in which aged mice were administered with low dose of levothyroxine for 3 consecutive months. Results showed that the aged rats exhibited an obvious improvement in cognitive and an increased rat survival rate from 60% to 93%. The underlying mechanism was demonstrated that levothyroxine treatment can increase the levels of choline acetyltransferase ...

Nasal mucosal inhalation of AD vaccine attenuates Aβ1-42-induced cytotoxicity

2014-07-09

Cholinergic inhibitors and N-methyl-D-aspartate receptor antagonists can alleviate the symptoms of Alzheimer's disease, but fail to affect irreversible cognitive dysfunction and effectively scavenge amyloid beta peptide in the brain. Amyloid beta peptide (Aβ) vaccines reduced and eliminated Aβ deposition in an Alzheimer's disease (AD) transgenic mouse model, and significantly improved behavioral and cognitive impairment. Dr. Yunpeng Cao and his team, First Affiliated Hospital of China Medical University, China immunized AD transgenic mouse models with Plp-Adeno-X-CMV-(Aβ3-10)10-CpG ...

Night-time brilliance lights up political patronage

2014-07-09

In some countries, a region that can lay claim to being the birthplace of a country's political leader is likely to get preferential treatment – bias that shines out when the intensity of night lights is compared with that in other regions. This new approach to pinpointing regional favouritism has been developed by researchers from Monash University and the University of St Gallen. Using information on the birthplaces of political leaders in 126 countries, and satellite data on night-time light intensity from 38,427 subnational regions from 1992-2009, they established ...

Adolescents from southern Europe are less fit and more obese than central-northern European peers

2014-07-09

Adolescents in southern Europe are less fit in terms of cardiorespiratory capacity, strength and speed-agility than their central-northern European peers. Moreover, southern adolescents are more obese and present higher levels of total and abdominal fat than those from the centre-north of Europe. These are some of the remarkable results from an ambitious study conducted by scientists from the University of Granada Department of Medical Physiology in collaboration with 25 other European research groups. The study compared the level of physical fitness of adolescents living ...

Cinnamon may be used to halt the progression of Parkinson's disease

2014-07-09

(CHICAGO) – Neurological scientists at Rush University Medical Center have found that using cinnamon, a common food spice and flavoring material, can reverse the biomechanical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD). The results of the study were recently published in the June 20 issue of the Journal of Neuroimmune Pharmacology. "Cinnamon has been used widely as a spice throughout the world for centuries," said Kalipada Pahan, PhD, study lead researcher and the Floyd A. Davis professor of neurology at Rush. "This ...

Rockefeller scientists first to reconstitute the DNA 'replication fork'

2014-07-09

When a cell divides, it must first make a copy of its DNA, a fundamental step in the life cycle of cells that occurs billions of times a day in the human body. While scientists have had an idea of the molecular tools that cells use to replicate DNA—the enzymes that unzip the double-stranded DNA and create "daughter" copies—they did not have a clear picture of how the process works. Now, researchers at Rockefeller University have built the first model system to decipher what goes on at the "replication fork"—the point where DNA is split down the middle in order to create ...

Depression in AMD patients with low vision can be halved by integrated therapies

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: